MaculaCare

New York, New York 10021

0 studies enrolling now · 21 studies all time

What they study most

"Wet" Age-Related Macular Degeneration, Age-Related Maculopathy, Diabetic Macular Edema, Diabetic Macular Edema (DME), Diabetic Retinopathy, Full-thickness Macular Holes (MH), Geographic Atrophy, Macular Degeneration, Neovascular (Wet) Age-related Macular Degeneration (AMD), Neovascular Age Related Macular Degeneration, Neovascular Age-related Macular Degeneration, Proliferative Diabetic Retinopathy

Studies at this site

• Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD — Running, not enrolling
• Fenofibrate for Prevention of DR Worsening — Running, not enrolling
• A Study to Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD] — Completed
• DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME — Completed
• Anti-VEGF Treatment for Prevention of PDR/DME — Completed
• Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA) — Completed
• Effects of Pneumatic Vitreolysis on Vitreomacular Traction — Completed
• Effects of Pneumatic Vitreolysis on Macular Hole — Completed
• Phase 4 IOP Signals Associated With ILUVIEN® — Completed
• Anti-VEGF vs. Prompt Vitrectomy for VH From PDR — Completed
• PROMINENT-Eye Ancillary Study (Protocol AD) — Stopped early
• Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema — Completed
• Treatment for CI-DME in Eyes With Very Good VA Study — Completed
• Phase II Combination Steroid and Anti-VEGF for Persistent DME — Completed
• Ocriplasmin Research to Better Inform Treatment (ORBIT) — Completed
• A Retrospective Chart Review of Patients Treated With Ocriplasmin for Symptomatic VMA — Completed
• Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD) — Completed
• Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD) — Status unconfirmed
• A Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for "Wet" Age-Related Macular Degeneration — Stopped early
• Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis — Paused
• Long-Term Efficacy in AMD of Rheopheresis in North America — Status unconfirmed